Literature DB >> 7341961

Amino acid sequence studies of human properdin--N-terminal sequence analysis and alignment of the fragments produced by limited proteolysis with trypsin and the peptides produced by cyanogen bromide treatment.

K B Reid, J Gagnon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341961     DOI: 10.1016/0161-5890(81)90112-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  7 in total

1.  Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

2.  Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

3.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 4.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Cloning and characterization of the cDNA encoding guinea-pig properdin: a comparison of properdin from three species.

Authors:  K K Maves; S T Guenthner; P Densen; D R Moser; J M Weiler
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

Review 6.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  Characterization of the human properdin gene.

Authors:  K F Nolan; S Kaluz; J M Higgins; D Goundis; K B Reid
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.